Skip to main content
. 2016 Oct 24;39(1):19–25. doi: 10.1080/0886022X.2016.1244073

Table 6.

Anti-rejection therapies received by AMR patients.

Anti-rejection therapy n (52)
CS + ATG + IVIg + R+PP + E 1
CS + IVIg + R+PP + E+A 1
CS + ATG + IVIg + R+PP 1
CS 2
CS + ATG 2
CS + ATG + IVIg 2
CS + ATG + R+PP 3
CS + R+PP 4
CS + IVIg + R+PP 5
CS + ATG + IVIg + PP 5
CS + ATG + PP 7
CS + IVIg + PP 8
CS + PP 11

A: alemtuzumab; ATG: anti-thymocyte globulin; E: eculizimab; IVIg: intravenoz immunoglobulin; CS: corticosteroid pulse; PP: plasmapheresis; R: rituximab.